Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00053131
Recruitment Status : Completed
First Posted : January 28, 2003
Last Update Posted : March 8, 2011
Information provided by:
Roswell Park Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2004
  Study Completion Date : February 2004